This training of Tyroserleutide Phase III clinical trial in the Second Affiliated Hospital Zhejiang University School of Medicine was held at Hangzhou Sunny Hotel on 27 August 2011, and some related experts of the Second Affiliated Hospital Zhejiang University School of Medicine attended the conference. The vice-present of Kangzhe Pharmaceutical Research and Development (Shenzhen) Limited introduced the research process of Tyroserleutide as well as the background and the prospect of the Tyroserleutide Phase III clinical trial, and our medical department also introduced the protocol, operation procedure and standardized procedure of Tyroserleutide Phase III clinical trial. Medpace (the Clinical Research Organization of this clinical trial) also explained Good Clinical Practice rules for us. The success of this training laid a solid foundation for the Phase III clinical research of Tyroserleutide.